Windtree Therapeutics has announced plans to purchase up to $700 million in BNB (the fifth-largest digital coin) following its recent all-time high. The Nasdaq-listed biotechnology firm is securing up to $520 million to facilitate these purchases and has engaged the cryptocurrency exchange Kraken for custody and trading services. Initially, Windtree had aimed to buy $200 million in BNB but has since expanded its commitment due to the coin's rising market value, currently priced at around $769. The firm’s CEO emphasized that acquiring additional funds to invest in BNB is a critical part of their strategy. The trend of publicly traded companies acquiring cryptocurrencies continues, represented by examples such as Windtree and another firm, Nano Labs, which recently announced a plan to buy $1 billion worth of BNB. Despite a current slight decline in stock value, Windtree's share price has surged by 162% over the past month, highlighting the impactful investment strategy in digital assets.

Source đź”—